|Day Low/High||2.98 / 2.99|
|52 Wk Low/High||1.45 / 3.28|
NEW YORK, Sept. 18, 2019 /PRNewswire/ -- Juan Monteverde , founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Empire State Building in New York City, is investigating: Mam Software Group, Inc.
NEW YORK, Sept. 17, 2019 /PRNewswire/ -- Bragar Eagel & Squire, P.
Former Attorney General of Louisiana Charles C. Foti, Jr.
Castle Creek will advance multiple late-stage clinical development programs targeting epidermolysis bullosa
- Total consideration of $63.3 million, including repayment of debt and other financial instruments - - Acquisition expected to close in the fourth quarter of 2019 - - Further strengthens Castle Creek Pharmaceuticals as a leader in dermatology - EXTON, Pa.
- Company to Host Conference Call and Webcast on Thursday, August 15 at 8:30 a.m.
Few parts of the market have more volatility than the small caps in this sector.
We are seeing a focus on finding smaller names that may offer interesting valuations and stories.
Company to Host Conference Call and Webcast Today at 8:30 a.m. EST
Company to Host Conference Call and Webcast Today at 8:30 a.m. EDT
Gene Therapy Candidate under Control of RheoSwitch Therapeutic System® Technology is Potential First-in-Class Treatment for Chronic Disease with High Unmet Need
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.